John Paulson’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-17,675
Closed -$972K 34
2022
Q2
$972K Buy
+17,675
New +$927K 0.05% 31

Other funds holding SRRA

John Paulson's SRRA Position: Q3 2022 in Review

John Paulson sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2022, closing a stake of 17,675 shares — an estimated $972K sold.

John Paulson first reported a position in SRRA in Q2 2022 and held it in 1 quarter. The position peaked at $972K in Q2 2022. 1 fund tracked by Wall St. Rank holds SRRA as of Q3 2022.

  • John Paulson reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • John Paulson sold 17,675 Sierra Oncology, Inc. Common Stock shares in Q3 2022, an estimated $972K.
  • John Paulson first reported a position in Sierra Oncology, Inc. Common Stock in Q2 2022 and held it in 1 quarter.
  • John Paulson's Sierra Oncology, Inc. Common Stock position peaked at $972K in Q2 2022.
  • 1 fund tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2022.

Based on Paulson & Co's 13F filing for Q3 2022, filed 14 Nov 2022.